文化大學機構典藏 CCUR:Item 987654321/53449
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 46833/50693 (92%)
Visitors : 11844636      Online Users : 1034
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/53449


    Title: 企業社會責任與企業績效研究:藥品 和生物技術產業個人主義和 長期導向的調節效果分析
    Corporate Social Responsibility and Corporate Performance: An Analysis of the Moderating Effect of Individualism and Long-Term Orientation in the Drugs and Biotechnology Industry
    Authors: 丁凱琳
    TING, KATHERINE GRACE REYES
    Contributors: 全球商務碩士學位學程碩士班
    Keywords: Corporate Social Responsibility
    drugs and biotechnology
    individualism
    long-term orientation
    Dynamic Network Slacks-Based Measure (DNSBM)
    corporate performance
    Date: 2024
    Issue Date: 2024-07-16 13:33:34 (UTC+8)
    Abstract: This study analyzed how environmental, social, and governance (ESG) performance affected the corporate performance of 36 drugs and biotechnology companies belonging to the Forbes Global 2000. A two-stage dynamic network slacks-based measure (DNSBM) was used to assess their innovation and profitability efficiencies from 2016 to 2021. This study revealed a two-fold benefit of strong ESG performance. More specifically, higher social pillar scores result in greater innovation and profitability efficiency. Furthermore, this study suggests that cultural factors influence how ESG performance translates into a company’s overall success. Companies operating in cultures characterized by high individualism and long-term orientation will reap the benefits of higher innovation efficiency by improving their social pillar scores. On the other hand, companies operating in cultures characterized by collectivism and short-term orientation will reap the benefits of higher innovation efficiency by improving their governance pillar scores. As the drugs and biotechnology industry is highly competitive, this study recommends that companies take a strategic approach to their ESG activities, while considering cultural factors in their planning and implementation to ensure long-term success and sustainability.
    Appears in Collections:[English Program of Global Business] Thesis

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML55View/Open


    All items in CCUR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback